Trinity Life Sciences vs ZoomRx: When "Integrated" Means Different Things

Trinity Life Sciences is the competitor that makes us work hardest to explain ourselves. With over 25 years of pharma-specialist experience, a Performance Tracking Center of Excellence built to go "beyond simple ATU," and real investment in AI capabilities including Brand Insights AI, they're the firm that comes closest to what we do on paper. Their high-touch, boutique model is genuine, and their research reflects it. But for brand teams evaluating Trinity or looking for an alternative that actually delivers on the integration promise, there's an important gap between intent and architecture. At launch scale, that gap compounds.

What Trinity Life Sciences Does Well

Trinity's research is rigorous and evidence-based. Their high-touch model means clients get real attention from experienced pharma researchers. Their TGaS Advisors network provides valuable commercial operations benchmarking. These are genuine strengths that earn them a place in a serious evaluation.

Where the Execution Gap Appears

1. Their integration happens at reporting, not at data collection

Even within Trinity's integrated framework, ATU tracking, promotional effectiveness, patient chart audits, and HCP dialogue work are designed and fielded as distinct research streams. Each has its own screener, its own physician sample, and its own timeline. Their integration happens when analysts synthesize findings across deliverables.

ZoomRx's integration happens before a single survey goes into field. The same physicians who answer ATU awareness questions also answer promotional recall questions and provide chart data, in one instrument, in one wave, from one screener. The connection between promotion, perception, and prescribing is measured at the respondent level, not inferred across separate samples. That's a fundamentally different kind of evidence.

2. Brand Insights AI queries past research. ZoomRx Answers queries this wave.

Brand Insights AI is a useful tool for searching completed research deliverables, including past reports, interview transcripts, and historical open-end summaries. Think of it as a research library. ZoomRx Answers is a live intelligence feed. When a wave closes, brand teams can immediately query those specific respondents in natural language, pull verbatim voice clips, and surface emerging patterns before the next planning cycle begins. One is retrospective. The other is real-time.

3. No proprietary HCP panel means you're waiting weeks for answers

Trinity recruits through third-party panel vendors for primary research. That creates the same speed constraint it creates for any vendor without owned panel access: rapid follow-ups take weeks to field. We maintain a proprietary panel of 60,000+ verified US physicians, which means follow-up studies field in days with no external feasibility process required.

4. Voice-first isn't part of their model

Trinity's tracking methodology is strong quantitative work with qualitative supplements commissioned as separate projects. ZoomRx embed audio open-ends directly within the quantitative tracking survey, not as a separate project, but in the same instrument. Every wave of quantitative data comes with the qualitative "why" built in, from the same respondents, at the same moment. The "why" isn't a follow-up deliverable at ZoomRx. It's part of the primary dataset.

5. Their technology is licensed, not owned

When Trinity's clients need a new question type, a custom survey feature, or a platform modification, Trinity has to work within the constraints of their technology partners and licensed platforms. We have an in-house technology team. Any feature request, including a new MaxDiff question, a specific output format, or a custom logic flow, can be built and deployed overnight. That agility gap compounds across a full launch program.

6. Their benchmarks are operations-focused, not launch-tracking-focused

Trinity's TGaS Advisors platform is excellent for commercial operations benchmarking, including headcount, field force structure, and budget norms. It isn't a launch performance tracking benchmark database. Our launch benchmarks come from primary research on actual ATU, PET, and patient chart data from comparable launches. That gives brand teams a direct apples-to-apples comparison on awareness trajectories, trial rates, promotional recall, and prescribing intent at equivalent time points.

Trinity Life Sciences vs ZoomRx: Side-by-Side

The Question That Decides It

"Show me how promotional exposure in your research connects to physician perception, which connects to prescribing intent, which connects to what your chart audit data shows — all from the same respondent pool, in the same data environment."

Trinity will show you a deliverable that synthesizes findings across separately fielded studies. ZoomRx connect the data before it's collected, at the screener level, so the physician answering your awareness questions is the same physician providing chart data. The connection is measured, not reconstructed.

See what data-level integration looks like in practice, and how your current launch research compares against benchmarks from 500+ comparable launches.

Frequently Asked Questions